Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What Sepracor products are on the market now, and how successful are they?

April 26, 2017market products sepracor successful

0

Posted

What Sepracor products are on the market now, and how successful are they?

1 Answer

0

Posted

We currently commercialize four proprietary products, LUNESTA® brand eszopiclone, XOPENEX® brand levalbuterol HCl Inhalation Solution, XOPENEX HFA® brand levalbuterol tartrate Inhalation Aerosol, a hydrofluoroalkane (HFA) metered-dose inhaler (MDI) and BROVANA® brand arformoterol tartrate Inhalation Solution.